antiarrhythmic drug

出典: meddic

抗不整脈薬

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/10/04 16:44:46」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Catheter ablation for ventricular tachycardia in structural heart disease.
  • Macintyre CJ1, Sapp JL2.Author information 1Heart Rhythm Service, Cardiology Division, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada.2Heart Rhythm Service, Cardiology Division, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: john.sapp@cdha.nshealth.ca.AbstractThe management of ventricular tachyarrhythmias has changed significantly over the past several decades. The advent of readily available implantable cardioverter defibrillators (ICDs) has had the greatest effect, with important mortality effects in patients with ventricular tachycardia and structural heart disease. ICDs have been shown to reduce sudden death in patients with ischemic and nonischemic cardiomyopathies; evidence of adverse consequences of ICD shocks, however, is mounting. In addition to the negative effects on patient-reported quality of life, anxiety, and depression, frequent ventricular arrhythmias and ICD shocks have also been associated with increased mortality. It is therefore important to identify and implement effective ventricular tachycardia-suppressive strategies. Antiarrhythmic drugs represent one such method, but are challenged by unfavourable side effect profiles and proarrhythmic risk. Catheter ablation of ventricular tachycardia is now a well-accepted intervention, which has been demonstrated to reduce recurrent arrhythmias. Questions persist regarding the optimal role for ablation compared with drug therapy.
  • The Canadian journal of cardiology.Can J Cardiol.2014 Feb;30(2):244-6. doi: 10.1016/j.cjca.2013.11.015. Epub 2013 Nov 20.
  • The management of ventricular tachyarrhythmias has changed significantly over the past several decades. The advent of readily available implantable cardioverter defibrillators (ICDs) has had the greatest effect, with important mortality effects in patients with ventricular tachycardia and structural
  • PMID 24373758
  • Antibiotic-induced Cardiac Arrhythmias.
  • Abo-Salem E, Fowler JC, Attari M, Cox CD, Perez-Verdia A, Panikkath R, Nugent K.Author information Department of Cardiovascular Diseases, University of Cincinnati, Cincinnati, OH, USA.AbstractThis review aims to clarify the underlying risk of arrhythmia associated with the use of macrolides and fluoroquinolones antibiotics. Torsades de pointes (TdP) is a rare potential side effect of fluoroquinolones and macrolide antibiotics. However, the widespread use of these antibiotics compounds the problem. These antibiotics prolong the phase 3 of the action potential and cause early after depolarization and dispersion of repolarization that precipitate TdP. The potency of these drugs, as potassium channel blockers, is very low, and differences between them are minimal. Underlying impaired cardiac repolarization is a prerequisite for arrhythmia induction. Impaired cardiac repolarization can be congenital in the young or acquired in adults. The most important risk factors are a prolonged baseline QTc interval or a combination with class III antiarrhythmic drugs. Modifiable risk factors, including hypokalemia, hypomagnesemia, drug interactions, and bradycardia, should be corrected. In the absence of a major risk factor, the incidence of TdP is very low. The use of these drugs in the appropriate settings of infection should not be altered because of the rare risk of TdP, except among cases with high-risk factors.
  • Cardiovascular therapeutics.Cardiovasc Ther.2014 Feb;32(1):19-25. doi: 10.1111/1755-5922.12054.
  • This review aims to clarify the underlying risk of arrhythmia associated with the use of macrolides and fluoroquinolones antibiotics. Torsades de pointes (TdP) is a rare potential side effect of fluoroquinolones and macrolide antibiotics. However, the widespread use of these antibiotics compounds th
  • PMID 24428853
  • Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation.
  • Sohns C, von Gruben V, Sossalla S, Bergau L, Seegers J, Lüthje L, Vollmann D, Zabel M.Author information Department of Cardiology and Pneumology, Heart Center, Georg-August-University of Göttingen, Göttingen, Germany; Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK.AbstractAIMS: The optimal pharmacological treatment for patients early after ablation of atrial fibrillation (AF) is still not clear. We analyzed if concomitant antiarrhythmic drug (AAD) therapy significantly alters early recurrence of AF/atrial tachycardia (AT) following pulmonary vein ablation (PVA).
  • Cardiovascular therapeutics.Cardiovasc Ther.2014 Feb;32(1):7-12. doi: 10.1111/1755-5922.12052.
  • AIMS: The optimal pharmacological treatment for patients early after ablation of atrial fibrillation (AF) is still not clear. We analyzed if concomitant antiarrhythmic drug (AAD) therapy significantly alters early recurrence of AF/atrial tachycardia (AT) following pulmonary vein ablation (PVA).METHO
  • PMID 24138075

和文文献

関連リンク

This scheme classifies a drug based on the primary mechanism of its antiarrhythmic effect. However, its dependence on primary mechanism is one of the limitations of the Singh-VW classification, since many antiarrhythmic agents have ...
22 Feb 2012 ... WebMD helps you understand how antiarrhythmic drugs can be used to help treat abnormal heart rhythms.

関連画像

Antiarrhythmic Drugs ClassificationAntiarrhythmic drugsAntiarrhythmic drug algorithm for the  to trying a different antiarrhythmic drugD0UH1ZUK9xC4ccq21h.Wtg.pngAmiodarone antiarrhythmic drug, chemical


★リンクテーブル★
リンク元抗不整脈剤」「myocardial depressant」「cardiac depressant
関連記事drug」「antiarrhythmic

抗不整脈剤」

  [★]

antiarrhythmic drugantiarrhythmic agentanti-arrhythmia agent
抗不整脈薬不整脈治療薬


myocardial depressant」

  [★]

anti-arrhythmia agentantiarrhythmic drugcardiac depressant

cardiac depressant」

  [★]

anti-arrhythmia agentantiarrhythmic drugmyocardial depressant

drug」

  [★]

drugs

WordNet   license wordnet

「use recreational drugs」
do drugs

WordNet   license wordnet

「administer a drug to; "They drugged the kidnapped tourist"」
dose

WordNet   license wordnet

「a substance that is used as a medicine or narcotic」

PrepTutorEJDIC   license prepejdic

「『薬』,薬品,薬剤 / 『麻薬』,麻酔剤 / 〈人〉‘に'薬(特に麻酔剤)を与える / 〈飲食物〉‘に'(麻酔薬・毒薬などの)薬を混ぜる」

antiarrhythmic」

  [★]

  • adj.
  • 抗不整脈の
  • n.
anti-arrhythmia agentantiarrhythmic agentantiarrhythmic drugantiarrhythmics


WordNet   license wordnet

「a drug used to treat an abnormal heart rhythm」
antiarrhythmic drug, antiarrhythmic medication




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡